<ѻý>AI System Outperforms Standard Review of Imaging for Retinal Diseaseѻý> Offers potential to reduce current manual grading workload Sep 25, 2023
<ѻý>The GLP-1 Agonist Plateau No One's Talking Aboutѻý> Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
<ѻý>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻý> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻý>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻý> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻý>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Sayѻý> Privacy policies, terms of sale often are unclear Sep 18, 2023
<ѻý>Keto for Kids With Diabetes Carries Risk, AAP Warnsѻý> American Academy of Pediatrics outlines policy for low-, very low-carbohydrate diets Sep 18, 2023
<ѻý>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻý> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻý>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortageѻý> Health news and commentary from around the Web gathered by ѻý staff Sep 12, 2023
<ѻý>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat?ѻý> "This is not your grandmother's heat," says policy expert Sep 10, 2023
<ѻý>New Weight-Loss Drugs Spark Debate About Safety During Surgeryѻý> Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
<ѻý>Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Showsѻý> All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
<ѻý>Case Grows for SGLT2 Inhibitors as Gout Treatmentѻý> Large cohort study shows expansive benefits Aug 28, 2023
<ѻý>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guidelineѻý> Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<ѻý>Should People Without Diabetes Use Glucose Monitors?ѻý> Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
<ѻý>Kombucha Shows Potential Diabetes Benefit in Small Trialѻý> Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
<ѻý>Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Eventsѻý> Anti-VEGF therapy raises risk of systemic events; retinal effects of diabetes drugs differ Jul 31, 2023
<ѻý>Albuminuria Testing Falling Short in Patients at Risk for CKDѻý> If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
<ѻý>Aspartame Is a 'Possible' Carcinogen, WHO Declaresѻý> But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
<ѻý>NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancerѻý> Several-fold higher risks compared with NAFLD patients without diabetes Jul 11, 2023
<ѻý>ASA: Hold GLP-1 Agonists Before Elective Surgeryѻý> Or else run the risk of aspirating under anesthesia due to delayed gastric emptying Jun 30, 2023
<ѻý>Diabetes Projected to Affect 1.3 Billion People by 2050ѻý> Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
<ѻý>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Aloneѻý> Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<ѻý>Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2Dѻý> Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
<ѻý>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Lossѻý> Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
<ѻý>Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trialѻý> Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
<ѻý>Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerantѻý> More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
<ѻý>Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetesѻý> Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
<ѻý>Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trialѻý> Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
<ѻý>Novel Agent Leads to Fibrosis Improvement in NASHѻý> Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
<ѻý>First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetesѻý> Now another oral option other than metformin Jun 21, 2023
<ѻý>Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gapsѻý> Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
<ѻý>Type 2 Diabetes Cases in Kids Still Rising After 'Return to Normal'ѻý> Once they returned to school, we thought things would normalize, researcher says Jun 20, 2023
<ѻý>Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetesѻý> Effects in small study seen independent of weight loss Jun 18, 2023
<ѻý>Anti-VEGF Injections for Diabetic Retinopathy Linked to Systemic Adverse Eventsѻý> But question of associated adverse effects is still far from settled, editorialist says Jun 02, 2023
<ѻý>Is Berberine Really 'Nature's Ozempic'?ѻý> An obesity medicine specialist shares his insights on the new social media craze Jun 02, 2023
<ѻý>More Evidence Backs Gout Benefit for Gliflozin Agentsѻý> New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
<ѻý>FDA Warns on Certain Forms of Compounded Semaglutideѻý> Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
<ѻý>Sotagliflozin Gets FDA's Blessing for Heart Failureѻý> SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
<ѻý>Topical Esmolol Gel Helped Heal Diabetic Foot Ulcersѻý> Significantly better than standard of care at 12 and 24 weeks May 15, 2023
<ѻý>Senators Call Out PBMs, Drugmakers for High Prescription Drug Costsѻý> This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023